These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 11735742

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
    Ray WA, MacDonald TM, Solomon DH, Graham DJ, Avorn J.
    Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
    [No Abstract] [Full Text] [Related]

  • 4. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
    Atkinson HG.
    Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].
    Bannwarth B.
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B79-84. PubMed ID: 11449148
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Gastric protective pain therapy. What is the advantage of new COX-2 inhibitors?].
    Hinz B, Brune K.
    MMW Fortschr Med; 2000 Mar 16; 142(11):39-40. PubMed ID: 10786088
    [No Abstract] [Full Text] [Related]

  • 9. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs.
    Perazella MA, Tray K.
    Am J Med; 2001 Jul 16; 111(1):64-7. PubMed ID: 11448662
    [No Abstract] [Full Text] [Related]

  • 10. COX-2 inhibitors. Magic bullets or merely mortal?
    Harv Health Lett; 2000 Feb 16; 25(4):4. PubMed ID: 10637015
    [No Abstract] [Full Text] [Related]

  • 11. [Specific inhibitors of cyclooxygenase type 2] ].
    Tomasová-Studýnková J.
    Vnitr Lek; 2002 May 16; 48(5):403-8. PubMed ID: 12061207
    [Abstract] [Full Text] [Related]

  • 12. The coxibs, selective inhibitors of cyclooxygenase-2.
    FitzGerald GA, Patrono C.
    N Engl J Med; 2001 Aug 09; 345(6):433-42. PubMed ID: 11496855
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of COX 2 inhibitors.
    Jones R.
    BMJ; 2002 Sep 21; 325(7365):607-8. PubMed ID: 12242157
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ, Burke TA, Whelton A, von Allmen H, Henderson SC.
    Am J Manag Care; 2002 Oct 21; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [Abstract] [Full Text] [Related]

  • 16. COX-2 inhibitors: new drugs for the management of pain and inflammation.
    Hutchins V, Hutchins B.
    Dent Today; 2001 Feb 21; 20(2):56-61. PubMed ID: 12524847
    [No Abstract] [Full Text] [Related]

  • 17. Coxibs and cardiovascular disease.
    Fitzgerald GA.
    N Engl J Med; 2004 Oct 21; 351(17):1709-11. PubMed ID: 15470192
    [No Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
    Fernandez H, Lesser GT.
    JAMA; 2000 Apr 19; 283(15):1961; author reply 1962. PubMed ID: 10789661
    [No Abstract] [Full Text] [Related]

  • 19. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
    Palmer RH.
    JAMA; 2000 Apr 19; 283(15):1961-2. PubMed ID: 10789662
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.